Koninklijke DSM NV (RDSMY)

Koninklijke DSM Financial Statements


Koninklijke DSM Financial Overview

Koninklijke DSM's market cap is currently ―. The company's EPS TTM is $1.828; its P/E ratio is 16.42; and it has a dividend yield of 1.80%. Koninklijke DSM is scheduled to report earnings on February 14, 2023, and the estimated EPS forecast is $0.48. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Sep 20
Income Statement
Total Revenue€ ―€ ―€ ―€ 2.08B€ 1.96B
Gross Profit€ ―€ ―€ ―€ ―€ ―
EBIT€ ―€ ―€ ―€ 107.00M€ 192.00M
EBITDA€ ―€ ―€ ―€ 107.00M€ 192.00M
Net Income Common Stockholders€ ―€ ―€ ―€ 98.00M€ 165.00M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments€ 914.00M€ 1.59B€ 1.63B€ 1.73B€ 1.85B
Total Assets€ 16.85B€ 16.01B€ 15.10B€ 14.35B€ 14.27B
Total Debt€ 2.57B€ 3.09B€ 3.09B€ 3.58B€ 3.80B
Net Debt€ 1.65B€ 1.50B€ 1.46B€ 1.86B€ 1.95B
Total Liabilities€ 7.03B€ 6.62B€ 6.50B€ 6.86B€ 6.86B
Stockholders Equity€ 9.73B€ 9.32B€ 8.52B€ 7.40B€ 7.32B
Cash Flow
Free Cash Flow€ ―€ ―€ ―€ 290.00M€ 278.00M
Operating Cash Flow€ ―€ ―€ ―€ 504.00M€ 406.00M
Investing Cash Flow€ ―€ ―€ ―€ -996.00M€ 502.00M
Financing Cash Flow€ ―€ ―€ ―€ -320.00M€ -517.00M
Currency in EUR

Koninklijke DSM Earnings and Revenue History

Koninklijke DSM Debt to Assets

Koninklijke DSM Cash Flow

Koninklijke DSM Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis